View Article

Abstract

One of the main causes of death is cancer, and its incidence is steadily rising throughout the world. Numerous illnesses, including cancer, have been treated with traditional medicine, its active compounds, and certain natural products. There are a number of medications on the market to treat different kinds of cancer, but none of them have been proven to be completely safe and effective. The toxicity of the current medications is the main issue with cancer chemotherapy. Nonetheless, plants and medicines derived from them have shown promise in the management and treatment of cancer. There are numerous natural compounds, and some of them have been found to have strong anticancer properties. Nowadays, the majority of cancer medication research involves..

Keywords

Cancer cell, Natural products, Plants, Carcinoma, medicinal plant, Alkaloids, Anticancer agents.

Introduction

Plants have been used to treat illnesses for as long as civilization [1], and traditional medicines continue to play a significant role in the routine treatment of various illnesses [2]. Due to historical, cultural, and other factors, folk medicine has gained popularity recently, particularly in underdeveloped nations with little access to healthcare. Serious negative consequences could result, nevertheless, if medicinal herbs are not scientifically evaluated to support their usage [3]. Biologically active materials are thought to be mostly found in plants. Eighty percent of rural residents use medicinal plants as their primary healthcare system, according to recent figures [4]. In both industrialized and developing nations, cancer is one of the most common illnesses. It is a class of diseases where body cells divide abnormally and uncontrollably, which can be fatal.Normal cells are    typically invaded and destroyed by cancer   cells.Therefore, we can regulate the development of cancer if we limit or stop this cell division.Despite spending billions of dollars on research, we still do not fully understand what cancer is.Millions of people receive a cancer diagnosis each   year, which results in their death.Approximately 3500 million people wordwide lose their lives to cancer.A number of chemopreventive me icines are used to treat cancer, but their toxicity limits their applications.

What Causes Cancer?

Mutations in DNA, which tell cells how   to divide and proliferate, may be the first cause of cancer. Most DNA mutations can be fixed by       normal cells, but those that cannot be    fixed and cause the cell to proliferate can turn into cancer [5]. The History of Traditional Medicine Medicinal plants have been used to treat various diseases for thousands of   years and in many parts of the world [6]. Humans used medicinal plants before   60,000 years ago, according to fossil records [7]. Today, plants remain the main source of medicine in rural areas of developing nations [8], and it is estimated that 80% of people in these countries still   use medicinal plants for their health       care [9].

Ayurvedic Concept of Cancer

Both Charaka and Sushruta Samhita [10,11] referred to the cancer's counterpart as "Granthi" and "Arbuda" [12]. Depending on the dosage, "Granthi" and "Arbuda" can either be inflammatory or non-inflammatory [13]. Ayurveda defines health as the balanced coordination of the body, mind, and consciousness of the three doshas “Vatta, Pitta, and Kapha” that cause disease [14]. The loss of mutual coordination among the three main body humors causes a morbid condition, which is why tridoshicarbudas are typically malignant [15].

Role Of Plants as Medicinal and Anticancer Agent

Since the beginning of human civilization, plants have been used as a source of food, shelter, and medicine. It is estimated that 80–85% of the world's population relies on traditional medicines for their primary health care needs, and it is assumed that a large portion of traditional therapy involves the use of plant extracts or their active principles [16,17,18]. While many recent studies have been conducted to advance the treatment and control of cancer progression, there is still much work to be done and room for improvement. The main drawbacks of synthetic drugs are the side effects they cause, but plant-derived products are much safer and have much lower toxicity than synthetic chemical drugs. When the cytotoxic podophyllotoxins were isolated and the vinca alkaloids (vinblastin and vincristine) were discovered and developed in the 1950s, the hunt for anticancer agents from plant sources began [19].

The Use of Plants in Cancer Therapy

cancer patients is constantly increasig Approximately 2to3 percent of deaths      worldwide are caused by various forms of    cancer [20], and the available treatment options include surgery, chemotherapy, and radiation [21]. The rising costs of traditional treatments, such as chemotherapy and radiation, and the lack of effective medications to treat solid tumors have led to a greater reliance on traditional medicine, which is based on the use of medicinal plants [22].  These plants have an almost limitless capacity to produce substances that draw researchers looking for new and innovative chemotherapeutics [23].  Despite the fact that some plant      products     are used in cancer therapy,  plant derived anticancer agents only make  up onefourth of the available treatmentoptions. Nine plantderived compoundsVinblastin, Vincristin, navelbine, Etoposide, Teniposide, Taxol, Taxotere, topotecan, and irinote can have been approved for use in cancer therapy in   the United States since 1961 [24]. Plant-Derived Anticancer Agents in Clinical Use.

Fig.1 [51]

1.Vinca Alkaloids

Vinca alkaloids are a significant family   of anticancer medications. Vinblastine (VLB) and vincristine (VCR), two significant naturally occurring chemicals derived from the Madagascar periwinkle, Catharanthus roseus G. Don. (Apocynaceae), were the first agents to be used in therapeutic settings.These   medications were found while looking  for oral hypoglycemics.Researchers found that plant extracts  triggered bone marrow depression    in   rats and dramatically decreased       white blood cell numbers,  albeit they    were   unable to substantiate this     activity.Mice with transplantable lymphocytic     leukemia also live longer thanks to plant   extract.Vincristine and vinblastine, two active alkaloids, were isolated after additional extraction and fractionation.Although the plant was native to Madagascar, samples used to identify vincristine and inblastine were gathered in Jamaica and the Philippines.The semisynthetic   analogues of vinca alkaloids vindesine      (VDS) and vinorelbine (VRLB) have been    developed recently.These are mostly used to treat a range of malignancies, either by themselves or in conjunction with other chemotherapy medications.VLB is used to treat Kaposi’s sarcoma, lymphomas, leukemias, breast cancer, testicular cancer,    and lung cancer.Additionally, VCR demonstrated effectiveness against leukemia, specifically juvenile acute lymphocytic leukemia [25,26].When compared to other vinca alkaloids, vinflunine, a bifluorinated derivative of vinorelbine, has better anticancer activity.Both vinflunine and vinorelbine show decreased toxicity in animal models, and this new vinca alkaloid is presently undergoing phase II clinical studies [27, 28]. 

Fig.2 [52]

2.Allium Sativum

In India, Allium sativum, commonly known as garlic or ginger, is used to treat a wide range of illnesses.Allicin is the main ingredient in raw garlic, and allicin rearranges to produce ajoene.Its cytotoxin action has been evaluated using human primary fibroblasts, a tumorigenic lymphoid cell line obtained   from a burkit lymphoma, and a permanent nontumorigenic cell line produced from baby lamster kidney cells.The range of the cytotoxic activity was 250 ug/m l29.In a number of animal models, some organo sulfur compounds found in garlic,   such as sallylesteine, have been shown to track the development of chemically produced and transplantable tumors [30].Garlic may have anticancer effects, according to the National Cancer Institute, which is part of the NIH.Garlic (250 mg/kg, p.o., three times a week) significantly inhibited the development of tongue carcinogenesis caused by nitroquinoline1oxide in male wistar rats, as evidenced by the absence of carcinomas during the initiation phase and their decreased occurrence during the postinitiation phase [31].Garlic's sulphydryl components have the power to prevent the development of chemicals that cause cancer.Increased garlic consumption has been linked in a number of population studies to a lower risk of pancreatic, esophageal, colon, stomach, and breast cancers [32].

Fig.3 [53]

3. Silybum Marianum

The milk thistle plant, Silybum marianum, yielded the flavonoid compound silymarin.Silymarin was investigated for its ability to prevent UV induced skin cancer in mice.Silymarin treatment demonstrated a strong anticancer effect, lowering the likelihood of tumor incidence to 60%, tumor multiplicity to 78%, and tumor volume per mouse to 90% [33].Cell cycle arrest at the G1/Sphase, induction of cyclindependent kinase inhibitors, downregulation of antiapoptotic gene product, inhibition of cellsurvival kinases, and inhibition of inflammatory transcription factors are some of the ways that silymarin suppresses the growth of tumor cells.Additionally, it was discovered that silymarin inhibited gene products linked to tumor cell proliferation, invasion, angiogenesis, and metastasis [34].One of the main components of Silybum marianum fruits, silibinin (flavanolignan), is also helpful in treating breast cancer in humans [35].

Fig.4 [54]

4. Podophyllotoxin Derivative

Podophyllum peltatum Linnaeus and P. emodii Wallich are two species of the Podophyllaceae family that have a long history of therapeutic use, including the treatment of warts and skin cancers.Native American people have utilized podophyllum peltatum to treat “cancer.”The discovery in the 1940s that a topical application of an alcohol extract of the dried roots, known as podophyllin, treats venereal warts sparked interest.Although podophyllotoxins were the main cytotoxic medicinal ingredients and were isolated for the first time in 1880, it was not until the 1950s that spectroscopic techniques advanced enough to reveal its true composition.During this time, other closely related podophyllotoxins, such as lignans, were also isolated and put into clinical trials; however, their ineffectiveness and intolerable toxicity led to their withdrawal.In the 1960s and 1970s, Sandoz Laboratories in Switzerland conducted extensive research that resulted in the development of etoposide and teniposide as clinical agents that are currently being used to treat lymphomas as well as bronchial and testicular cancers. As of July 2004, the NCI had recorded 2069 anticancer clinical trials in progress, of which more than 150 were drug combinations that included etoposide against various cancers [36,37].

Fig. 5 [55]

5.Taxanes

The creation of a class of molecules known as taxanes represents a more recent development in the creation of chemotherapeutic agents derived fromplants.The bark of Taxus brevifolia Nutt. (Taxaceae) is where paclitaxel, commonly known as taxol, was initially isolated.They entered the market in the 1990s after their structure was initially discovered in 1971.While the leaves of T. baccata are used in Ayurveda, with one use in treating “cancer,” several Native American tribes have documented using various parts of T. brevifolia and other Taxus species (e.g., T. canadensis Marshall, T. baccata L.) to treat certain noncancerous conditions.A significant, renewable natural source of this significant class of medications is the readily semi-synthetic conversion of the relatively abundant baccatins to paclitaxel and active paclitaxel analogs, like docetaxel (Taxotere). Paclitaxel is biosynthesised and found in the leaves of several Taxus species.In addition to being effective against Kaposi sarcoma, paclitaxel is used to treat a wide range of malignancies, such as breast, ovarian, and non-smallcell lung cancer.Additionally, it has garnered interest because of its potential for treating rheumatoid arthritis, multiple sclerosis, and psoriasis [38].It was discovered that docetaxel, a semisynthetic derivative of paclitaxel, was more efficient. Patients who are resistant to paclitaxel may be treated with docetaxel.For patients with ovarian, breast, or metastatic cancer, docetaxel and paclitaxel are utilized as first- and secondline treatments, respectively [39].

Fig.6 [56]

6.Curcumin

Curcumin (diferuloylmethane), a polyphenolic compound that was isolated from the Indian plant species Curcuma longa (commonly called turmeric), is now being used as a potential anticancer compound. While turmeric is primarily promoted as an antiinflammatory herbal remedy, some scientists think that the antioxidant curcumin in turmeric may prevent or slow the growth of many cancers, including tumors of the esophagus, stomach, and intestine, breast cancer, and skin cancer in experimental animals. Curcumin is involved in modulating the cell cycle pathway and induced apoptosis of various cancer cells, though the precise mechanism of action has not yet been thoroughly studied. Phase I/II trials are currently being conducted to determine how curcumin affects colorectal cancer, multiple myeloma, and pancreatic cancer [40,41].Known for its antiinflammatory, antiviral, antibacterial, antifungal, and anticancer properties, curcumin is used in Chinese medicine and as the yellow coloring ingredient in curry, a traditional Indian dish. It may also help treat diabetes, allergies, arthritis, and Alzheimer's disease.discussed curcumin and proposed that agents that target multiple genes, like curcumin, are necessary for cancer prevention and treatment because the majority of cancers are caused by dysregulation of up to 500 different genes         [42].

7.Camellia Sinensis (Green Tea)

Green tea and occasionally black tea include polyphenols that aid in the death of malignant cells and the prevention of their spread.In green tea, epigallocatechin3gallate (EGCG) is the most prevalent polyphenol.Patients with chronic lymphocytic leukemia (CLL), a kind of blood cancer, had fewer leukemia cells because to green tea's epigalloacatechin gallate (EGCG).According to certain epidemiological research, EGCG can prevent human colon and oral cancer cells from invading and migrating.Reduced MMP2, MMP9, and uPA synthesis may be partially responsible for the effects of EGCG [43].Additionally, it was found that EGCG inhibited the growth of cancer cell lines such as hepatocellular carcinoma by inducing cell cycle arrest [44], inhibited the growth of cancer cells in ovarian carcinoma cell lines HEY and OVCA, and inhibited the growth of cancer cells in human colon and rectal cancer cell lines HT29 and HCA7 [45,46,47,48]. In addition, studies found that women who drank powdered green tea had a lower risk of bladder cancer, and that men who drank the most green tea had a 37 percent lower risk of pancreatic cancer. A large Chinese clinical study found that the risk of prostate cancer decreased as the frequency and quantity of green tea consumption increased, but that green tea could decrease the likelihood of breast cancer recurrence but not prevent or improve breast cancer [50].

CONCLUSION

This review article offers details on natural medicines and herbs that may be able to treat or slow the spread of cancer. A number of clean, efficient agents for the treatment of various cancers have been found in natural materials and their derivatives.It is well known that medicinal plants have strong anticancer properties. When discussing anticancer treatments, they are frequently mentioned as a major source of synthetic or herbal ingredients.The use of natural medicines derived from medicinal plants is crucial in the fight against cancer.In animal models of sarcoma, skin cancer, and leukemia, they have demonstrated anticancer activity.

REFRENCES

        1. Fabricant, D. & Farnsworth, N. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109 (1), 69-75.
        2. Alviano, D. & Alviano, A. (2009). Plant extracts: search for new alternative to treat microbial diseases. Current Pharmaceutical Biotechnology, 10, 106-121.
        3. Souza, G., Hass, A., Poser, G., Schapoval, E., & Elisabetsky, E. (2004). Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. Journal of Ethnopharmacology, 90 (1), 135-143.
        4. Sakarkar, D. & Deshmukh, V. (2011). Ethnopharmacological review of traditional medicinal plants for anticancer activity. International Journal of Pharma Tech Research, 3, 298 308.
        5. Krishnamurthi K. Screening of natural products for anticancer and antidiabetic properties. Health Administrator. XX (1&2): 69, (2000).
        6. Palombo, E. (2009). Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential aplication in the prevention and treatment of oral diseases. Evidence-based Complementary and Alternative doi:10.1093/ecam/nep067. Medicine,
        7. Fabricant, D. & Farnsworth, N. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109 (1), 69-75.
        8. Chitme, H., Chandra, R., & Kaushik, S.(2003). Studies on anti-diarrheal activity of Calotropis Gigantea R. Br. in eperimental animals. Journal of Pharmacy and Pharmaceutical sciences, 7, 70-75.
        9. Kim, H. (2005). Do not put too much value on conventional medicines. Journal of Ethnopharmacology, 100, 37-39.
        10. Charaka. Charaka Samhita. Chaukhamba Publications, Varanasi, India; 700 BC: 215.
        11. Susruta. Susruta Samhita. Chaukhamba Publications, Varanasi, India ; 700 BC: 520.
        12. Misra B. Bhawa Prakash Nighantu. Chaukhamba Publications, Varanasi, India; 1600 AD: 29
        13. Kapoor L. D. Handbook of ayurvedic medicinal plants. CRC Press, Florida; 1990.
        14. Balachandran P, Govindarajan R., Cancer- an ayurvedic perspective. Pharmacology Research, 51. 19. 2005.
        15. Singh R. H., An assessment of the ayurvedic concept of cancer and a new paradigm of anticancer treatment in Ayurveda. Journal of Alternative & Complementary Medicine, 8. 609. 2002.
        16. Ignacimuthu S, Ayyanar M, Sivaraman S.K., Ethnobotanical investigations among tribes in Madurai district of Tamil Nadu (India). Journal of Ethnobiology and Ethnomedicine, 2. 1. 2006.
        17. Elujoba A. A., Odeleye O. M., Ogunyemi C. M., Traditional medicine development for medical and dental primary health care delivery system in Africa. African Journal of Traditional, Complementary and Alternative Medicines, 2. 46. 2005.
        18. Tomlinson T. R., Akerele O., Medicinal plants: their role in health and biodiversity. University of Pennsylvania Press, Philadelphia, 1998.
        19. Gordon M. C., David J., Plants as a source of anti-cancer agents. Journal of Ethnopharmacology, 100. 72. 2005.
        20. Madhuri, S. and Pandey G. (2009).Some anticancer medicinal plants of foreign origin.Current science,96(6),779-782.
        21. Tannock F.(1998).Conventional Cancer therapy:Promise broken or promisedelayed?. Lancet,352,9-16.
        22. Wood-Sheldon,J,.,Balick,M.and Laird,S.(91997).Medicinal plants:Can utilization and conservation Coexist?.The New York Botanical Garden.USA.
        23. Reed,J.and Pellecchia,M.(2005).Apoptosis-based therapies for hematologic malignancies,blood,106,408-418.
        24. Lee, K. (1999). Anticancer drug design based on plant-derived natural products. Journal of Biomedical Science, 6, 236-350.
        25. Gueritte F., Fahy J., The vinca alkaloids. In Anticancer Agents from Natural Products, edited by Cragg GM, Kingston DGI, Newman DJ. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, Chapter 7. 23. 2005.
        26. Cragg,G.M., Newman, D.J.,(2005). Plants as a source of anticancer agenta. J Ethnopharmacol.,100:72-79.
        27. Okouneva, T.,Hill, B.T., WILSON, L., Jordan, M.A., (2003). The effects of vinflunine,vinorelbine, and vinblastine on centromere dynamics. Mol cancer ther.,2:427-436.
        28. Simoens, C., Lardon, F., Pauwels, B., De Pooter, C.M.J., Lambrechts, H.A.J., Pattyn,G.G.O., Breillout, F., Vermorken, J.B., (2008). Comparative study of the radiosensitising and cell cycle effect of vinflunine and vinorelbine, in vitro. BMC cancer.,8:65.
        29. Scharfenberg K., Wagner R., Wagner K.G., The cytotoxic effect of ajoene, a natural product from garlic, investigated with different cell lines. Cancer Letters, 53(2-3). 103. 1990.
        30. Thomson M., Ali M., Garlic (Allium sativum): a review of its potential use as an anti-cancer agent. Current Cancer Drug Targets, 3(1). 67. 2003.
        31. Banasenthil S., Ramachandran C.R., Nagini S., Prevention of 4 nitroquinoline-1-oxide induced rat tongue carcinogenesis by garlic. Fitoterapia, 72. 524. 2001.
        32. Ranjani R, Ayya RM. Anticancer Properties of Allium sativum A Review, Asian Journal of Biochemical and Pharmaceutical Research. 2012; 3 (2): 190-196.
        33. Agarwal R., Agarwal C., Ichikawa H., Singh R.P., Agarwal B.B., Anticancer potential of silymarin: from bench to bed side. Anticancer Research, 26(6B). 4457. 2006.
        34. Kim S., Choi J. H., Lim H. I., Lee S. K., Kim W.W., Kim J. S., et al., Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells, Phytomedicine, 16(6-7). 573. 2009.
        35. Li Y. L., Gan G. P., Zhang H. Z., Wu H. Z., Li C. L., Huang Y. P., Liu Y. W., Liu J. W., A flavonoid glycoside isolated from Smilax china L. rhizome in vitro anticancer effects on human cancer cell lines. Journal of Ethnopharmacology, 113(1). 115. 2007.
        36. Lee K.H., Xiao Z., Podophyllotoxins and analogs. In Anticancer Agents from Natural Products, edited by Cragg GM, Kingston DGI, Newman DJ. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, Chapter 5. 71. 2005.
        37. Shoeb, M., MacManus,S.M.,Jaspars, M.,TRevidadu, J., Nahar, L., Thoo-Lin, P.K., Sarker, S.D., (2006). Montamine, a unique dimeric indole alkaloid, from the seeds of Centaurea montana (Asteraceae), and its in -vitro cytotoxin activity against the CaCo2 colon cancer cells.Tetrahedron.,62:11172-77
        38. Kingston D. G. I., Taxol and its analogs. In Anticancer Agents from Natural Products, edited by Cragg GM, Kingston DGI, Newman DJ. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, Chapter 6. 89. 2005.
        39. Hait,W.N., Rubin, E., Alli, E.,Goodin, S., (2007). Tubulin targeting agents. Update on cancer therapeutics.,2:1-18.
        40. Sa, G., Das, T., Banerjee, S., Chakraborty, J., (2010). Curcumin:from exotic spice to modern anticancer drug. AI Ameen J Med Sci.,3:21-37.
        41. Goel, A., Kunnumakkara, A.B., Aggarwal, B.B.,(2008). Curcumin as “Curecumin”: from kitchen to clinic. Biochem. Pharmacol.,75:787-809.
        42. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signalling proteins. Cancer Lett. 2008; 269: 199-225.
        43. Ho Y. C., Yang S.F., Peng C. Y., Chou M. Y., Chang Y. C., Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix etalloproteinases and urokinase-plasminogen activator. Journal of Oral Pathol Medicine, 36. 588. 2007.
        44. Nishikawa T., Nakajima T., Moriguchi M., Jo M., Sekoguchi S., Ishii M. et al., A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Journal of Hepatology, 44. 1074. 2006.
        45. Spinella F., Rosano L., Decandia S., Di C.V., Albini A., Elia G., Natali P.G., Bagnato A., Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target. Exp Biol Med, 231. 1123. 2006 a.
        46. Spinella F., Rosano L., Di C.V., Decandia S., Albini A., Nicotra M.R., Natali P.G., Bagnato A., Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Therapy, 5. 1483. 2006 b.
        47. Hwang J. T., Ha J., Park I. J., Lee S. K., Baik H. W., Kim Y. M., Park O. J., Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Letters, 247. 115. 2007.
        48. Peng G., Dixon D.A., Muga S. J., Smith T.J., Wargovich M. J., Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Molecular Carcino, 45. 309. 2006.
        49. Hu Z., Yang Y., Ho P.C., Chan S. Y., Heng P. W., Chan E., Duan W., Koh H.L., Zhou S., Herb-drug interactions: a literature review. Drugs, 65. 1239. 2005.
        50. Ishii T, Mori T, Tanaka T, Mizuno D, Yamaji R, Kumazawa S, Nakayama T, Akagawa M. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Free Radic Biol Med. 2008; 45: 1384-1394.
        51. https://images.app.goo.gl/or2z1kbMLNqiQDiq9
        52. https://images.app.goo.gl/B6sUETGKWqEpymyV7
        53. https://images.app.goo.gl/2XpR9v47vvgHfheW9.

Reference

  1. Fabricant, D. & Farnsworth, N. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109 (1), 69-75.
  2. Alviano, D. & Alviano, A. (2009). Plant extracts: search for new alternative to treat microbial diseases. Current Pharmaceutical Biotechnology, 10, 106-121.
  3. Souza, G., Hass, A., Poser, G., Schapoval, E., & Elisabetsky, E. (2004). Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. Journal of Ethnopharmacology, 90 (1), 135-143.
  4. Sakarkar, D. & Deshmukh, V. (2011). Ethnopharmacological review of traditional medicinal plants for anticancer activity. International Journal of Pharma Tech Research, 3, 298 308.
  5. Krishnamurthi K. Screening of natural products for anticancer and antidiabetic properties. Health Administrator. XX (1&2): 69, (2000).
  6. Palombo, E. (2009). Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential aplication in the prevention and treatment of oral diseases. Evidence-based Complementary and Alternative doi:10.1093/ecam/nep067. Medicine,
  7. Fabricant, D. & Farnsworth, N. (2001). The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives, 109 (1), 69-75.
  8. Chitme, H., Chandra, R., & Kaushik, S.(2003). Studies on anti-diarrheal activity of Calotropis Gigantea R. Br. in eperimental animals. Journal of Pharmacy and Pharmaceutical sciences, 7, 70-75.
  9. Kim, H. (2005). Do not put too much value on conventional medicines. Journal of Ethnopharmacology, 100, 37-39.
  10. Charaka. Charaka Samhita. Chaukhamba Publications, Varanasi, India; 700 BC: 215.
  11. Susruta. Susruta Samhita. Chaukhamba Publications, Varanasi, India ; 700 BC: 520.
  12. Misra B. Bhawa Prakash Nighantu. Chaukhamba Publications, Varanasi, India; 1600 AD: 29
  13. Kapoor L. D. Handbook of ayurvedic medicinal plants. CRC Press, Florida; 1990.
  14. Balachandran P, Govindarajan R., Cancer- an ayurvedic perspective. Pharmacology Research, 51. 19. 2005.
  15. Singh R. H., An assessment of the ayurvedic concept of cancer and a new paradigm of anticancer treatment in Ayurveda. Journal of Alternative & Complementary Medicine, 8. 609. 2002.
  16. Ignacimuthu S, Ayyanar M, Sivaraman S.K., Ethnobotanical investigations among tribes in Madurai district of Tamil Nadu (India). Journal of Ethnobiology and Ethnomedicine, 2. 1. 2006.
  17. Elujoba A. A., Odeleye O. M., Ogunyemi C. M., Traditional medicine development for medical and dental primary health care delivery system in Africa. African Journal of Traditional, Complementary and Alternative Medicines, 2. 46. 2005.
  18. Tomlinson T. R., Akerele O., Medicinal plants: their role in health and biodiversity. University of Pennsylvania Press, Philadelphia, 1998.
  19. Gordon M. C., David J., Plants as a source of anti-cancer agents. Journal of Ethnopharmacology, 100. 72. 2005.
  20. Madhuri, S. and Pandey G. (2009).Some anticancer medicinal plants of foreign origin.Current science,96(6),779-782.
  21. Tannock F.(1998).Conventional Cancer therapy:Promise broken or promisedelayed?. Lancet,352,9-16.
  22. Wood-Sheldon,J,.,Balick,M.and Laird,S.(91997).Medicinal plants:Can utilization and conservation Coexist?.The New York Botanical Garden.USA.
  23. Reed,J.and Pellecchia,M.(2005).Apoptosis-based therapies for hematologic malignancies,blood,106,408-418.
  24. Lee, K. (1999). Anticancer drug design based on plant-derived natural products. Journal of Biomedical Science, 6, 236-350.
  25. Gueritte F., Fahy J., The vinca alkaloids. In Anticancer Agents from Natural Products, edited by Cragg GM, Kingston DGI, Newman DJ. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, Chapter 7. 23. 2005.
  26. Cragg,G.M., Newman, D.J.,(2005). Plants as a source of anticancer agenta. J Ethnopharmacol.,100:72-79.
  27. Okouneva, T.,Hill, B.T., WILSON, L., Jordan, M.A., (2003). The effects of vinflunine,vinorelbine, and vinblastine on centromere dynamics. Mol cancer ther.,2:427-436.
  28. Simoens, C., Lardon, F., Pauwels, B., De Pooter, C.M.J., Lambrechts, H.A.J., Pattyn,G.G.O., Breillout, F., Vermorken, J.B., (2008). Comparative study of the radiosensitising and cell cycle effect of vinflunine and vinorelbine, in vitro. BMC cancer.,8:65.
  29. Scharfenberg K., Wagner R., Wagner K.G., The cytotoxic effect of ajoene, a natural product from garlic, investigated with different cell lines. Cancer Letters, 53(2-3). 103. 1990.
  30. Thomson M., Ali M., Garlic (Allium sativum): a review of its potential use as an anti-cancer agent. Current Cancer Drug Targets, 3(1). 67. 2003.
  31. Banasenthil S., Ramachandran C.R., Nagini S., Prevention of 4 nitroquinoline-1-oxide induced rat tongue carcinogenesis by garlic. Fitoterapia, 72. 524. 2001.
  32. Ranjani R, Ayya RM. Anticancer Properties of Allium sativum A Review, Asian Journal of Biochemical and Pharmaceutical Research. 2012; 3 (2): 190-196.
  33. Agarwal R., Agarwal C., Ichikawa H., Singh R.P., Agarwal B.B., Anticancer potential of silymarin: from bench to bed side. Anticancer Research, 26(6B). 4457. 2006.
  34. Kim S., Choi J. H., Lim H. I., Lee S. K., Kim W.W., Kim J. S., et al., Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells, Phytomedicine, 16(6-7). 573. 2009.
  35. Li Y. L., Gan G. P., Zhang H. Z., Wu H. Z., Li C. L., Huang Y. P., Liu Y. W., Liu J. W., A flavonoid glycoside isolated from Smilax china L. rhizome in vitro anticancer effects on human cancer cell lines. Journal of Ethnopharmacology, 113(1). 115. 2007.
  36. Lee K.H., Xiao Z., Podophyllotoxins and analogs. In Anticancer Agents from Natural Products, edited by Cragg GM, Kingston DGI, Newman DJ. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, Chapter 5. 71. 2005.
  37. Shoeb, M., MacManus,S.M.,Jaspars, M.,TRevidadu, J., Nahar, L., Thoo-Lin, P.K., Sarker, S.D., (2006). Montamine, a unique dimeric indole alkaloid, from the seeds of Centaurea montana (Asteraceae), and its in -vitro cytotoxin activity against the CaCo2 colon cancer cells.Tetrahedron.,62:11172-77
  38. Kingston D. G. I., Taxol and its analogs. In Anticancer Agents from Natural Products, edited by Cragg GM, Kingston DGI, Newman DJ. Brunner-Routledge Psychology Press, Taylor & Francis Group, Boca Raton, Chapter 6. 89. 2005.
  39. Hait,W.N., Rubin, E., Alli, E.,Goodin, S., (2007). Tubulin targeting agents. Update on cancer therapeutics.,2:1-18.
  40. Sa, G., Das, T., Banerjee, S., Chakraborty, J., (2010). Curcumin:from exotic spice to modern anticancer drug. AI Ameen J Med Sci.,3:21-37.
  41. Goel, A., Kunnumakkara, A.B., Aggarwal, B.B.,(2008). Curcumin as “Curecumin”: from kitchen to clinic. Biochem. Pharmacol.,75:787-809.
  42. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signalling proteins. Cancer Lett. 2008; 269: 199-225.
  43. Ho Y. C., Yang S.F., Peng C. Y., Chou M. Y., Chang Y. C., Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix etalloproteinases and urokinase-plasminogen activator. Journal of Oral Pathol Medicine, 36. 588. 2007.
  44. Nishikawa T., Nakajima T., Moriguchi M., Jo M., Sekoguchi S., Ishii M. et al., A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Journal of Hepatology, 44. 1074. 2006.
  45. Spinella F., Rosano L., Decandia S., Di C.V., Albini A., Elia G., Natali P.G., Bagnato A., Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target. Exp Biol Med, 231. 1123. 2006 a.
  46. Spinella F., Rosano L., Di C.V., Decandia S., Albini A., Nicotra M.R., Natali P.G., Bagnato A., Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Therapy, 5. 1483. 2006 b.
  47. Hwang J. T., Ha J., Park I. J., Lee S. K., Baik H. W., Kim Y. M., Park O. J., Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Letters, 247. 115. 2007.
  48. Peng G., Dixon D.A., Muga S. J., Smith T.J., Wargovich M. J., Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Molecular Carcino, 45. 309. 2006.
  49. Hu Z., Yang Y., Ho P.C., Chan S. Y., Heng P. W., Chan E., Duan W., Koh H.L., Zhou S., Herb-drug interactions: a literature review. Drugs, 65. 1239. 2005.
  50. Ishii T, Mori T, Tanaka T, Mizuno D, Yamaji R, Kumazawa S, Nakayama T, Akagawa M. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Free Radic Biol Med. 2008; 45: 1384-1394.
  51. https://images.app.goo.gl/or2z1kbMLNqiQDiq9
  52. https://images.app.goo.gl/B6sUETGKWqEpymyV7
  53. https://images.app.goo.gl/2XpR9v47vvgHfheW9.

Photo
Patil Sunita
Corresponding author

N.B.S. Institute of Pharmacy, Ausa, dist. Latur, India.

Photo
Kalal Laxmi
Co-author

N.B.S. Institute of Pharmacy, Ausa, dist. Latur, India.

Patil Sunita, Kalal Laxmi, Anticancer Potential of Plant and Natural Product, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 3, 1477-1485. https://doi.org/10.5281/zenodo.15034793

More related articles
A Comprehensive Review On: Barleria Cristata Linn....
Mrityunjoy Mondal, Poonam Pant, Mahendra Rana, ...
A Review of Herbal Drugs Used in The Treatment of ...
GAYATRI DALVI*, VISHAKHA SHINDE , SHINDE TRUPTI, SWAPNIL KALE,...
Review of Herbal Interventions for Atopic Dermatit...
ANAGHA MOHAN, Dr. ARUN KUMAR , MEGHA V. S., HARITHA K., M. ROSHNI...
Photodynamic Therapy: A Safe And Effective Treatment Option For Bladder Cancer ...
Pranali V. Ghate, Akshaykumar A. Kedar, Jaya P. Ambhore, Vaibhav S. Adhao, Harshal M. Naik, Aditya V...
A Review on The Role of Jamun, Syzygium Cumini Skeels In Treatment of Diabetes ...
Shubhangi Jadhav , Tejaswini Bhadake, Dr. Gajanan Sanap, ...
Related Articles
Review: Amygdalin Loaded Nanoparticles in Cancer Treatment...
Mahek Mahebub Shaikh , Ajit Pawar, Dr. Megha Salve, ...
Comparative Study of Antibacterial Activity of Aqueous and Ethanolic Extract of ...
Jaseela K. P., Anusree Sreedharan, Hidha Muthalib Abdul Muthalib, ...
Novel Way to Kill the Cancer Cells...
Bonthu Bhavani Satya Prasad , Vendra Sruthi , Shaik Parveen, ...
A Comprehensive Review On: Barleria Cristata Linn. (Acanthaceae)...
Mrityunjoy Mondal, Poonam Pant, Mahendra Rana, ...
More related articles
A Comprehensive Review On: Barleria Cristata Linn. (Acanthaceae)...
Mrityunjoy Mondal, Poonam Pant, Mahendra Rana, ...
A Review of Herbal Drugs Used in The Treatment of Skin Disorder ...
GAYATRI DALVI*, VISHAKHA SHINDE , SHINDE TRUPTI, SWAPNIL KALE, Sneha Kanase, MS. DIVYA GORE, ...
Review of Herbal Interventions for Atopic Dermatitis/ Eczema: Types, Etiology, E...
ANAGHA MOHAN, Dr. ARUN KUMAR , MEGHA V. S., HARITHA K., M. ROSHNI, SANDHRA S., SINDHU V., ...
A Comprehensive Review On: Barleria Cristata Linn. (Acanthaceae)...
Mrityunjoy Mondal, Poonam Pant, Mahendra Rana, ...
A Review of Herbal Drugs Used in The Treatment of Skin Disorder ...
GAYATRI DALVI*, VISHAKHA SHINDE , SHINDE TRUPTI, SWAPNIL KALE, Sneha Kanase, MS. DIVYA GORE, ...
Review of Herbal Interventions for Atopic Dermatitis/ Eczema: Types, Etiology, E...
ANAGHA MOHAN, Dr. ARUN KUMAR , MEGHA V. S., HARITHA K., M. ROSHNI, SANDHRA S., SINDHU V., ...